High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.
很抱歉, 生成此内容时发生错误。

EasySep™小鼠TIL(CD45)正选试剂盒



沪公网安备31010102008431号